{"id":"W2962768820","doi":"10.1016/j.lungcan.2019.07.021","title":"The rate of occurrence, healthcare resource use and costs of adverse events among metastatic non-small cell lung cancer patients treated with first- and second-generation epidermal growth factor receptor tyrosine kinase inhibitors","year":2019,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"AstraZeneca","keywords":"Medicine; Erlotinib; Afatinib; Adverse effect; Internal medicine; Gefitinib; Lung cancer; Population; Epidermal growth factor receptor; Rate ratio; Cancer; Oncology; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008003813,0.0002302254,0.0003747961,0.00009037938,0.0001371219,0.00001126767,0.00004872407,0.00005831541,0.0000643676],"category_scores_gemma":[0.00002737072,0.0001489432,0.00004724546,0.0002247839,0.00009592716,0.0002185453,0.00002974137,0.0001177271,4.345241e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003126755,"about_ca_system_score_gemma":0.0002618861,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005536805,"about_ca_topic_score_gemma":0.005807912,"domain_scores_codex":[0.9987626,0.00009227438,0.0003724737,0.0003352257,0.0001914686,0.0002459659],"domain_scores_gemma":[0.9987255,0.0001575751,0.0003860745,0.0002044685,0.0003677487,0.0001586046],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0003784727,0.000111888,0.994222,0.0008644633,0.0002937446,0.000001902366,0.001204539,0.00007560731,0.001216862,0.000005127367,0.001205655,0.0004197074],"study_design_scores_gemma":[0.006850989,0.0006264142,0.9708676,0.001587043,0.0008576281,9.941838e-7,0.0002147172,0.001341104,0.01711413,5.494438e-7,0.0003138285,0.0002250164],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9939445,0.002481798,0.000006798449,0.0002210866,0.0001968685,0.001820542,0.001290911,0.00001206812,0.0000254699],"genre_scores_gemma":[0.9978523,0.0008495541,0.00007790743,0.0001158966,0.00004096756,0.000213483,0.0002643119,0.00002719658,0.000558336],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02335444,"threshold_uncertainty_score":0.837003,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01153341486082002,"score_gpt":0.2730662465461996,"score_spread":0.2615328316853796,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}